06 July 2022

safety alerts

Reference: CIR-2022-00000139

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

 

Zolgensma (onasemnogene abeparvovec): Safety Update of Fatal Cases of Acute Liver Failure

Copiktra (duvelisib): Drug Safety Communication - Possible Increased Risk of Death and Serious Side Effects

Medical device Alert CARESCAPE R860 Ventilator

Lifting the Suspension on the Registration& Marketing of the Product Gupisone Syrup

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

تحديث السلامة بالنسبة للحالات المميتة من الفشل الكبدي الحاد - Zolgensma-1.pdf:

View Document

تحذير بخصوص المستحضر الصيدلاني Copiktra - duvelisib-1.pdf:

View Document

تقارير السلامة للوسائل الطبية - CARESCAPE-1.pdf:

View Document

رفع التعليق عن تسجيل وتسويق المنتج الطبي - Gupisone - Julphar-.pdf:

View Document